The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Raw data underlying figures 1–7. by Alejandra Barrera-Rosales (21656278)

Subjects:

Participant characteristics. by Ronald Kusolo (13200268)

Subjects:

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Breaking strength and ash contents in the tibia. by Miloš Skřivan (5122037)

Subjects:

Performance characteristics of broilers. by Miloš Skřivan (5122037)

Subjects:

Digesta viscosity and pH in the ileum. by Miloš Skřivan (5122037)

Subjects:

Nutrient retention in broilers (g/kg/day). by Miloš Skřivan (5122037)

Subjects:

Fatty acid composition (mg/100 g) of breast meat. by Miloš Skřivan (5122037)

Subjects:

Fat contents (g/kg) in breast meat and liver. by Miloš Skřivan (5122037)

Subjects:

Summary of previous work. by Junyan Wang (4738518)

Subjects:

Comparison of MAP@0.5 results from experiments. by Junyan Wang (4738518)

Subjects:

YOLO11. by Junyan Wang (4738518)

Subjects:

Structure of the SCI-YOLO11 network. by Junyan Wang (4738518)

Subjects:

Comparative experimental results. by Junyan Wang (4738518)

Subjects: